R
Roland Benz
Researcher at Jacobs University Bremen
Publications - 406
Citations - 20726
Roland Benz is an academic researcher from Jacobs University Bremen. The author has contributed to research in topics: Membrane & Lipid bilayer. The author has an hindex of 75, co-authored 399 publications receiving 19923 citations. Previous affiliations of Roland Benz include Tokai University & University of Bari.
Papers
More filters
Journal ArticleDOI
A new electrical method for the determination of the cell membrane area in plant cells
TL;DR: The membrane area of giant algal cells of Valonia utricularis was determined electrically by using the charge-pulse technique and agrees with the geometrically determined one to within 10%.
Journal ArticleDOI
Chloroquine Analog Interaction with C2- and Iota-Toxin in Vitro and in Living Cells
TL;DR: It is demonstrated that positively charged aminoquinolinium salts are able to block channels formed in lipid bilayer membranes by the binding components of C2- and Iota-toxin and protect cultured mammalian cells from intoxication with these molecules.
Journal ArticleDOI
Molecular Cloning and Functional Characterization of the Paracoccus Denitrificans Porin
TL;DR: In this paper, the porin from Paracoccus denitrificans has been shown to form trimeric pores that show no ion selectivity in potassium chloride solution, which indicates that the charges within or near the channel are balanced.
Journal ArticleDOI
Identification of two porins in Pelobacter venetianus fermenting high-molecular-mass polyethylene glycols.
TL;DR: Porins were purified from cells of the anaerobic gram-negative bacterium Pelobacter venetianus grown with 20-kDa polyethylene glycol to show cationically selective channels and a channel conducted ammonium much better than potassium or rubidium ions, suggesting that it is probably involved in ammonium uptake.
Book ChapterDOI
Toxin Transport by A-B Type of Toxins in Eukaryotic Target Cells and Its Inhibition by Positively Charged Heterocyclic Molecules
Roland Benz,Holger Barth +1 more
TL;DR: The novel toxin inhibitors should be attractive compounds for an application in combination with antibiotics to prevent or treat the diseases associated with binary toxins.